# Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert J. Motzer,Nizar M. Tannir,Ray McDermott,Osvaldo Arén Frontera,Bohuslav Melichar,Toni K. Choueiri,Elizabeth R. Plimack,Philippe Barthélémy,Camillo Porta,Saby George,Thomas Powles,Frede Donskov,Victoria Neiman,Christian Kollmannsberger,Pamela Salman,Howard Gurney,Robert D. Hawkins,Alain Ravaud,Marc‐Oliver Grimm,Sergio Bracarda,Carlos H. Barrios,Yoshihiko Tomita,Daniel Castellano,Brian I. Rini,Allen C. Chen,Sabeen Mekan,M. Brent McHenry,Megan Wind‐Rotolo,Justin Doan,Padmanee Sharma,Hans J. Hammers,Bernard Escudier |
| Citations | 4,691 |
| DOI | 10.1056/nejmoa1712126 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1712126?articleTools=true |
| OpenAlex ID | https://openalex.org/W2792937256 |
| PMID | 29562145 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Toni K. Choueiri](https://scholariq.org/researchers/toni-k-choueiri/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.